- Trials with a EudraCT protocol (426)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (10)
426 result(s) found for: Hematopoietic Stem Cell.
Displaying page 1 of 22.
EudraCT Number: 2016-002383-13 | Sponsor Protocol Number: Cord_Blood_Expansion_(SR-1) | Start Date*: 2016-10-18 | |||||||||||
Sponsor Name:Erasmus MC | |||||||||||||
Full Title: Umbilical cord blood transplantation in high-risk hematological patients using stemregenin-1 expanded hematopoietic stem cells. A feasibility study focussing on engraftment and hematopoietic recov... | |||||||||||||
Medical condition: Patients with high-risk hematological diseases, who need a allogeneic stem cell transplantation but who lack a matched unrelated donor | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001188-55 | Sponsor Protocol Number: HOVON115 | Start Date*: 2012-07-10 | |||||||||||
Sponsor Name:HOVON Foundation | |||||||||||||
Full Title: Double umbilical cord blood transplantation in high-risk hematological patients. A phase II study focussing on the mechanism of graft predominance | |||||||||||||
Medical condition: Patients with high-risk hematological diseases, who need a allogeneic stem cell transplantation but who lack a matched unrelated donor | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) BE (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001040-31 | Sponsor Protocol Number: TUD-RELAZA-008 | Start Date*: 2006-11-23 |
Sponsor Name:University of Technology Dresden | ||
Full Title: Treatment of the haematological relapse in patients suffering from acute myeloid leukaemia or myelodysplastic syndrome with 5-Azacytidin (Vidaza®) after hematopoietic stem cell transplantation "REL... | ||
Medical condition: Patients suffering from acute myeloid leukaemia or myelodysplastic syndrome with falling CD34-chimerism or relapse after hematopoietic stem cell transplantation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-013798-16 | Sponsor Protocol Number: | Start Date*: 2010-02-01 | |||||||||||||||||||||||||||||||
Sponsor Name:Royal Liverpool and Broadgreen University Hospitals NHS Trust | |||||||||||||||||||||||||||||||||
Full Title: A comparison of plerixafor/G-CSF with chemotherapy/G-CSF for stem cell transplantation | |||||||||||||||||||||||||||||||||
Medical condition: Patients with lymphoma or myeloma, who require high dose chemotherapy with autologous stem cell rescue (known colloquially as an autograft). Plerixafor is used to mobilise the autologous stem cells... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-003010-12 | Sponsor Protocol Number: APHP180600 | Start Date*: Information not available in EudraCT |
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | ||
Full Title: «Efficacy of Fluticasone Propionate associated with Salmeterol using inhalation chamber versus placebo to improve the respiratory function in children over six years of age who underwent allogeneic... | ||
Medical condition: Bronchiolitis Obliterative Syndrome after hematopoietic stem cell transplantation (HSCT). . | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004869-88 | Sponsor Protocol Number: HS2116100 | Start Date*: 2016-12-21 |
Sponsor Name:GlaxoSmithKline K.K. (GSK) | ||
Full Title: A multicenter, open-label study to evaluate preventive efficacy for herpes simplex virus infection and safety of 256U87 (valaciclovir hydrochloride) in adult and pediatric hematopoietic stem cell t... | ||
Medical condition: Herpes simplex virus (HSV) infection before and after hematopoietic stem cell transplantation. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2009-011817-26 | Sponsor Protocol Number: BHS-UCB2009 | Start Date*: 2010-10-21 |
Sponsor Name:UZ Brussel VUB | ||
Full Title: A pilot study to assess the feasibility of unrelated umbilical cord blood transplantation with coinfusion of third-party mesenchymal stem cells after myeloablative or nonmyeloablative conditioning ... | ||
Medical condition: Adult patients with hematological malignancies | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003403-19 | Sponsor Protocol Number: HCK1 | Start Date*: 2013-09-25 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Study of T- and B-cell immunity after vaccination with a virosomebased influenza vaccine (Inflexal V) in patients who have undergone hematopoietic allogeneic stem cell transplantation. | ||
Medical condition: Allogeneic stem cell transplantation | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003573-42 | Sponsor Protocol Number: 232100-0131 | Start Date*: 2014-11-11 |
Sponsor Name:Västra Götalandsregionen | ||
Full Title: Antibody-mediated immune response after immunization with FSME-Immun(R) against Tick Borne Encephalitis(TBE) after hematopoietic autologous and allogeneic stem cell transplantation. | ||
Medical condition: Patients have undergone allogeneic or autologous stem cell transplantation for hematological malignancies. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003626-88 | Sponsor Protocol Number: HOO-MSC01 | Start Date*: 2014-01-17 |
Sponsor Name:Fakultní nemocnice Plzeň | ||
Full Title: The utilization of mesenchymal stem cells (MSC) for the treatment of graft versus host disease (GVHD) after allogeneic stem cell transplantation. | ||
Medical condition: The study is intended for patients after allogeneic hematopoietic stem cell transplantation (from related and unrelated donors) with steroid-refractory or steroid-dependent GVHD of any type: - Ste... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-006367-26 | Sponsor Protocol Number: IGTRegs | Start Date*: 2023-01-03 |
Sponsor Name:Πανεπιστήμιο Πατρών | ||
Full Title: Phase I / II study of HLA-G + induced T-regulatory cells (iG-Tregs) in patients after allogeneic hematopoietic stem cell transplantation from HLA compatible sibling / donor. | ||
Medical condition: Adopt immunotherapy in adult patients undergoing hematopoietic stem cell (HSCT) transplantation from a fully compatible donor sibling for the prevention and treatment of GvHD. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004726-34 | Sponsor Protocol Number: SHP620-302 | Start Date*: 2017-09-01 | |||||||||||
Sponsor Name:Takeda Development Center Americas, Inc. | |||||||||||||
Full Title: A Phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled study to assess the efficacy and safety of maribavir compared to valganciclovir for the treatment of cytomegaloviru... | |||||||||||||
Medical condition: Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) GB (GB - no longer in EU/EEA) ES (Completed) BE (Completed) CZ (Completed) PL (Completed) FR (Completed) HR (Completed) IT (Completed) GR (Completed) AT (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002434-40 | Sponsor Protocol Number: AST-MOMA | Start Date*: 2012-03-23 | |||||||||||
Sponsor Name:University Hospital Tuebingen | |||||||||||||
Full Title: Highdose Chemotherapy and transplantation of 34+ selected stem cell for progressive systemic sclerosis Modification according to manifestation | |||||||||||||
Medical condition: Systemic sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000932-70 | Sponsor Protocol Number: APHP200067 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE -HOPITAUX DE PARIS | |||||||||||||
Full Title: Randomized prospective trial evaluating the efficacy of the antiCD38 monoclonal antibody isatuximab in the treatment of PCRA by major ABO mismatch after allogeneic hematopoietic stem cell transplan... | |||||||||||||
Medical condition: Pure cell red aplasia by major ABO mismatch after allogeneic hematopoietic stem cell transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003523-30 | Sponsor Protocol Number: 38RC17.191 | Start Date*: 2017-12-18 | |||||||||||
Sponsor Name:University Hospital Grenoble | |||||||||||||
Full Title: Vaccination after hematopoietic stem cell transplantation : a randomized study estimating the interest of an additional injection for patients not reponding at M3. | |||||||||||||
Medical condition: Our aim is to determine whether an additional dose of inactivated vaccine can increase the rate of responders among patients who have not responded adequately after 3 injections | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004101-26 | Sponsor Protocol Number: TJB0601P1 | Start Date*: 2006-12-13 | |||||||||||
Sponsor Name:CHU Sart-Tilman | |||||||||||||
Full Title: Mesenchymal stem cell infusion as prevention for graft rejection and graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning: a pilot study | |||||||||||||
Medical condition: Patients with hematological malignancies not candidate for conventional allogeneic transplantation because of age or comorbidities. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000659-10 | Sponsor Protocol Number: LMW-DS-103 | Start Date*: 2014-05-21 | |||||||||||
Sponsor Name:TikoMed AB | |||||||||||||
Full Title: A randomised, open-label, placebo-controlled, single centre study in healthy male volunteers to explore efficacy, safety and tolerability of single doses of low molecular weight dextran sulfate (LM... | |||||||||||||
Medical condition: Healthy volunteers (mobilization of haematopoietic stem cells) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: SE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003337-40 | Sponsor Protocol Number: final version 2.0 | Start Date*: 2006-02-13 |
Sponsor Name:European Group for Blood and Marrow Transplantation (EMBT) | ||
Full Title: Autologous Stem Cell Transplantation for Crohn's Disease ('ASTIC'-Trial: Autologous Stem Cell Transplantation International Crohn's Disease Trial) | ||
Medical condition: Patients with Crohn's disease who have not responded to immunosupressant medication | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) IT (Ongoing) BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001005-67 | Sponsor Protocol Number: AlloRelapseMMStudy | Start Date*: 2022-05-11 | |||||||||||
Sponsor Name:University Medical Center Hamburg-Eppendorf | |||||||||||||
Full Title: Allogeneic stem cell transplantation vs. conventional therapy as salvage therapy for relapsed / progressed patients with multiple myeloma after first-line therapy (AlloRelapseMMStudy) | |||||||||||||
Medical condition: Multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004725-23 | Sponsor Protocol Number: Penta-STs-001 | Start Date*: 2021-10-05 |
Sponsor Name:Γενικό Νοσοκομείο Θεσσαλονίκης "Γεώργιος Παπανικολάου" | ||
Full Title: Administration of rapidly generated multipathogen-specific T-Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus fumigatus infections post Allogeneic Stem Cell Transplant | ||
Medical condition: Hematopoietic stem cell transplant (HSCT) recipients with AdV, EBV, CMV, BKV or Aspergillus fumigatus (AF) infection/ reactivation or with active disease. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GR (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.